Basepair Partners with IWAI Chemicals to Bring Scalable, Cloud-Based Genomic Analysis to Japan

May 15, 2025 12:00 AM AEST | By EIN Presswire
 Basepair Partners with IWAI Chemicals to Bring Scalable, Cloud-Based Genomic Analysis to Japan
Image source: EIN Presswire

Empowering Japanese Researchers with End to End Genomic Solutions

Partnering with Basepair allows us to deliver a solution that meets modern R&D needs without increasing infrastructure burden.”
— Yoshiko Iwai, President & CEO of Iwai Chemicals
NEW YORK, NY, UNITED STATES, May 14, 2025 /EINPresswire.com/ -- Basepair Inc. and IWAI Chemicals Co., Ltd. today announced a strategic partnership to bring its cloud-based next-generation sequencing (NGS) analysis platform to Japan. The collaboration marks a major expansion of IWAI’s support for Japan’s life science researchers, adding powerful bioinformatics capabilities to its trusted lineup of reagents, equipment, and analytical services.

As genomic data becomes foundational to research in oncology, rare diseases, and infectious disease surveillance, many labs are struggling to keep up. IWAI recognized a growing demand among its customers—not just for reagents or instruments, but for easier, faster, and more cost-effective ways to analyze data at scale. This partnership with Basepair enables IWAI to offer exactly that: an intuitive, cloud-native solution that removes the technical friction from bioinformatics.

“Our customers face more data, less time, and tighter budgets. We see it as our role to help them stay ahead—not just with products, but with solutions,” said Yoshiko Iwai, President & CEO of Iwai Chemicals. “Partnering with Basepair allows us to deliver a solution that meets modern R&D needs without increasing infrastructure burden.”

The agreement builds on IWAI’s recent expansion into bioinformatics services, including contract analysis and expert staffing, and now extends into self-service, cloud-based NGS workflows via the Basepair platform. Researchers can now run pipelines like RNA-seq, scRNA-seq, and ATAC-seq through a simple drag-and-drop interface—no coding required—and explore interactive visualizations and reports in real-time.

“We’re excited to work with a partner that understands both the wet and dry lab sides of life science R&D,” said Simon Valentine, CCO of Basepair Inc. “IWAI’s deep relationships with Japan’s researchers make them the perfect ally to help scale smarter, faster genomics analysis.”

Unlike many existing Software-as-a-Service platforms, Basepair runs inside the customer’s own AWS account, allowing full control over security, compliance, and cloud costs. It also offers flexible per-sample licensing and a white-label business layer, enabling IWAI and its partners to bundle analysis services with kits or instruments and deliver real-time performance insights. The platform also optimizes compute instance use and includes automated S3 data archiving features that can reduce storage cloud costs by up to 80%.

About Basepair Inc.
Basepair Inc. is a market-leading point-and-click bioinformatics company focused on unlocking the full potential of NGS technology. By empowering more scientists to understand the meaning and value of genomic data, whilst eliminating sensitive data movement, it securely accelerates the scientific and diagnostic breakthroughs that bring lifesaving medicines and treatments to the patients who need them. To learn more, visit basepairtech.com

About IWAI Chemicals Co., Ltd.
IWAI Chemical has supported Japan’s life science community for decades with high-quality reagents, instruments, and services. Now entering the next phase of support, IWAI is expanding into bioinformatics to help researchers navigate the data-heavy future of biology. To learn more, visit iwaichem.com

Media Contacts:

Equipment/BI team
IWAI Chemicals Co., Ltd.
Tel: +81 80-1037-5032
E-Mail: [email protected]

Simon J Valentine
Basepair Inc
+1 858-263-9785
email us here
Visit us on social media:
LinkedIn
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.